Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance

BACKGROUND/AIMS: The novel prokinetic drug acotiamide is used for treatment of functional dyspepsia. It is still unclear how acotiamide has effects on esophageal motor function. Esophageal peristalsis and esophagogastric junction (EGJ) compliance has an important role for prevention of esophageal mu...

Full description

Saved in:
Bibliographic Details
Published in:J Neurogastroenterol Motil
Main Authors: Mikami, Hironobu, Ishimura, Norihisa, Okada, Mayumi, Izumi, Daisuke, Okimoto, Eiko, Ishihara, Shunji, Kinoshita, Yoshikazu
Format: Artigo
Language:Inglês
Published: Korean Society of Neurogastroenterology and Motility 2018
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885723/
https://ncbi.nlm.nih.gov/pubmed/29605979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm16111
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items